Načítá se...
MET receptor juxtamembrane exon 14 alternative spliced variant: Novel cancer genomic predictive biomarker
Clinical studies on MET-targeting cancer therapeutics yielded mixed results in recent years and MET relevant predictive biomarkers remain elusive. New studies now reveal METex14 alternative splicing aberrations to represent potential predictive cancer genomic biomarkers, hence renewing optimism and...
Uloženo v:
| Vydáno v: | Cancer Discov |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4617658/ https://ncbi.nlm.nih.gov/pubmed/26243862 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-15-0769 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|